Showing results (231-240 of 324) with videos related to

Sort By:
Pageof 33
Journal of Cancer|November 21, 2017
Development and Validation of a Nomogram to Predict the Benefit of Adjuvant Radiotherapy for Patients with Resected Gastric CancerShu-Qiang Yuan, Wen-Jing Wu, Miao-Zhen Qiu, et al.
Oncotarget|April 15, 2015
microRNA-217 inhibits tumor progression and metastasis by downregulating EZH2 and predicts favorable prognosis in gastric cancerDong-liang Chen, Dong-sheng Zhang, Yun-xin Lu, et al.
BMC Cancer|March 27, 2014
Primary small cell carcinoma of the esophagus: clinicopathological study of 44 casesWei-Wei Chen, Feng Wang, Dong-Sheng Zhang, et al.
Scientific Reports|December 2, 2015
A plasma cytokine and angiogenic factor (CAF) analysis for selection of bevacizumab therapy in patients with metastatic colorectal cancerLong Bai, Feng Wang, Dong-Sheng Zhang, et al.
American Journal of Cancer Research|November 12, 2021
PD-1 antibody camrelizumab for Epstein-Barr virus-positive metastatic gastric cancer: a single-arm, open-label, phase 2 trialYu-Ting Sun, Wen-Long Guan, Qi Zhao, et al.
Clinical and Translational Medicine|May 11, 2026
Sintilimab plus cisplatin and nab-paclitaxel induction treatment for locally advanced borderline-resectable oesophageal squamous cell carcinoma: A single-arm, prospective, phase 2 study (NEOCRTEC2001)Jia-Di Wu, De-Shen Wang, Zhi-Qiang Wang, et al.
Cancer Management and Research|May 24, 2019
A real-world evidence of efficacy of palliative gastrectomy plus chemotherapy in metastatic gastric cancer patientsLu-Ping Yang, Zi-Xian Wang, Ming-Ming He, et al.
Cancer|February 14, 2006
Lamivudine prophylaxis reduces the incidence and severity of hepatitis in hepatitis B virus carriers who receive chemotherapy for lymphomaYu-Hong Li, Yi-Fu He, Wen-Qi Jiang, et al.
Plos One|March 5, 2013
Reduced expression of ZDHHC2 is associated with lymph node metastasis and poor prognosis in gastric adenocarcinomaShu-Mei Yan, Jian-Jun Tang, Chun-Yu Huang, et al.
JAMA Network Open|May 4, 2019
Correlation of Milestone Restricted Mean Survival Time Ratio With Overall Survival Hazard Ratio in Randomized Clinical Trials of Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysisZi-Xian Wang, Hao-Xiang Wu, Li Xie, et al.
Pageof 33